These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31423199)
1. Bmi-1 in gallbladder carcinoma: Clinicopathology and mechanism of regulation of human gallbladder carcinoma proliferation. Jiao K; Jiang W; Zhao C; Su D; Zhang H Oncol Lett; 2019 Aug; 18(2):1365-1371. PubMed ID: 31423199 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Fan YZ; Fu JY; Zhao ZM; Chen CQ Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis. Luo HB; Li B; Yuan WG; Xu CR J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630 [TBL] [Abstract][Full Text] [Related]
4. Effect of CLIC1 gene silencing on proliferation, migration, invasion and apoptosis of human gallbladder cancer cells. He YM; Zhang ZL; Liu QY; Xiao YS; Wei L; Xi C; Nan X J Cell Mol Med; 2018 May; 22(5):2569-2579. PubMed ID: 29516682 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro. Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772 [TBL] [Abstract][Full Text] [Related]
6. [The role of tissue factor pathway inhibitor-2 gene in gallbladder cancer]. Qin YY; Gong W; Weng MZ; Li JY; Quan ZW Zhonghua Wai Ke Za Zhi; 2012 Dec; 50(12):1099-103. PubMed ID: 23336488 [TBL] [Abstract][Full Text] [Related]
7. [Artemisinin inhibits proliferation of gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis]. Jia JG; Zhang LG; Guo CX; Wang YG; Chen BL; Wang YM; Qian J Zhonghua Wai Ke Za Zhi; 2016 Mar; 54(3):222-7. PubMed ID: 26932893 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis. Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682 [TBL] [Abstract][Full Text] [Related]
9. mda-7/IL-24 induces apoptosis in human GBC-SD gallbladder carcinoma cells via mitochondrial apoptotic pathway. Jia J; Li S; Gong W; Ding J; Fang C; Quan Z Oncol Rep; 2011 Jan; 25(1):195-201. PubMed ID: 21109977 [TBL] [Abstract][Full Text] [Related]
10. MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma. Wang W; Chen LC; Qian JY; Zhang Q Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9829-9839. PubMed ID: 31799650 [TBL] [Abstract][Full Text] [Related]
11. Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Liu TY; Tan ZJ; Jiang L; Gu JF; Wu XS; Cao Y; Li ML; Wu KJ; Liu YB Cancer Cell Int; 2013 Jun; 13(1):64. PubMed ID: 23802572 [TBL] [Abstract][Full Text] [Related]
12. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo. Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607 [TBL] [Abstract][Full Text] [Related]
13. Effect of Tian C; Zhang B; Ge C Oncol Lett; 2020 Sep; 20(3):2677-2688. PubMed ID: 32782584 [TBL] [Abstract][Full Text] [Related]
14. UHRF1 depletion suppresses growth of gallbladder cancer cells through induction of apoptosis and cell cycle arrest. Qin Y; Wang J; Gong W; Zhang M; Tang Z; Zhang J; Quan Z Oncol Rep; 2014 Jun; 31(6):2635-43. PubMed ID: 24756644 [TBL] [Abstract][Full Text] [Related]
15. MiRNA-145 Induces Apoptosis in a Gallbladder Carcinoma Cell Line by Targeting DFF45. Yuan Y; Yang Z; Zou Q Open Life Sci; 2018 Jan; 13():227-235. PubMed ID: 33817087 [TBL] [Abstract][Full Text] [Related]
16. Expression and inhibitory effects of p53-upregulated modulator of apoptosis in gallbladder carcinoma. Liu Z; Yan C; Xiao Y; Zhang W; Wang L; Li Q; Cai W Oncol Lett; 2021 Mar; 21(3):234. PubMed ID: 33613723 [TBL] [Abstract][Full Text] [Related]
17. CCK1 receptor is involved in the regulation of protein lysine acetylation in GBC-SD cells and gallbladder carcinoma. Wu W; Ouyang B; Lu Z; Liu H; Tan Y; Cui P Ir J Med Sci; 2017 Nov; 186(4):883-888. PubMed ID: 28470351 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo. Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397 [TBL] [Abstract][Full Text] [Related]
19. Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT. Ye J; Qi L; Liang J; Zong K; Liu W; Li R; Feng R; Zhai W J Cancer; 2021; 12(12):3548-3557. PubMed ID: 33995632 [TBL] [Abstract][Full Text] [Related]
20. The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation. Quan ZW; Yang Y; Li JY; Gong W; Qin YY; Li SG Biomed Pharmacother; 2010 Sep; 64(7):451-7. PubMed ID: 20359855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]